Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant
نویسندگان
چکیده
منابع مشابه
Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
The interleukin-33 (IL-33)/ST2 pathway has emerged as an intercellular signaling system that participates in antigen-allergen response, autoimmunity and fibrosis. It has been suggested that IL-33/ST2 signaling has been involved in the pathogenesis of rheumatoid arthritis (RA), because IL-33 and its receptor have been specifically mapped to RA synovium. The aim of this study was to determine the...
متن کاملInterleukin (IL)-33: new therapeutic target for atopic diseases.
Interleukin (IL)-33, a member of the IL-1 family of cytokines, is produced when epithelial and endothelial cells are exposed to stimuli. Hematopoietic cells such as macrophages also produce IL-33. IL-33 is considered to function as an 'alarmin', activating various immune cells through its receptor ST2, which leads to the production of various molecules. The IL-33-induced production of pro-infla...
متن کاملInterleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12
The pro-Th2 cytokine IL-33 is now emerging as an important Th1 cytokine-IFN-γ inducer in murine CD4(+) T cells that is essential for protective cell-mediated immunity against viral infection in mice. However, whether IL-33 can promote human Th1 cell differentiation and how IL-33 polarizes Th1 cells is less understood. We assessed the ability of IL-33 to induce Th1 cell differentiation and IFN-γ...
متن کاملIL-33 and Airway Inflammation
Interleukin-33 (IL-33) is the 11th member of IL-1 cytokine family which includes IL-1 and IL-18. Unlike IL-1β and IL-18, IL-33 is suggested to function as an alarmin that is released upon endothelial or epithelial cell damage and may not enhance acquired immune responses through activation of inflammasome. ST2, a IL-33 receptor component, is preferentially expressed by T-helper type (Th) 2 cell...
متن کاملتغییرات اینترلوکین 33 (il-33) و اینترلوکین 23 (il-23) در بیماران مبتلا به آرتریت روماتوئید
پیش زمینه: آرتریت روماتوئید یک بیماری خودایمنی سیستمیک مزمن است که عمدتا به وسیله پاسخ های التهابی که روی مفاصل و بافت های اطراف آنها اثر می گذارند شناخته می شود. با وجودی که دلیل ابتلا به آرتریت روماتوئید ناشناخته است چنین به نظر می رسد که سیتوکین هایی که به وسیله سلول های مختلف مثل لنفوسیت ها، مونوسیت ها، سلول های اپی تلیال و اندوتلیال تولید می شوند نقش های مهمی را در القا و پیشبرد پاسخ های ا...
15 صفحه اولذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Biological Chemistry
سال: 2011
ISSN: 0021-9258
DOI: 10.1074/jbc.m111.219089